The incidence of venous thromboembolism: A prospective, community-based study in Perth, Western Australia

Medical Journal of Australia

Volumn 189, Issue 3, 2008, Pages 144-147

  Ho, Wai Khoon ^a   Hankey, Graeme J ^b   Eiketboom, John W ^c  

^a AUSTIN HEALTH   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; COMMUNITY LIVING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSPECTIVE STUDY; SEX DIFFERENCE; TREND STUDY; VENOUS THROMBOEMBOLISM;

EID: 50249111143     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb01947.x     Document Type: Article

References (22)

1. Fedullo PF. Pulmonary thromboembolism. In: Murray JF, Nadel JA, Mason RJ, Boushey HA, editors. Textbook of respiratory medicine. 3rd ed. Philadelphia: WB Saunders, 2000: 1503-1531.
2. Oger E; EPI-GETBP Study Group. Incidence of venous thromboembolism: a community-based study in Western France. Thromb Haemost 2000; 83: 657-660.
3. Kesteven P, Robinson B. Incidence of symptomatic thrombosis in a stable population of 650,000: travel and other risk factors. Aviat Space Environ Med 2002; 73: 593-596.
4. Kierkegaard A. Incidence of acute deep vein thrombosis in two districts. A phlebographic study. Acta Chit Scand 1980; 146: 267-269.
5. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 155-160.
6. Ward G, Jamrozik K, Stewart-Wynne E. Incidence and outcome of cerebrovascular disease in Perth, Western Australia. Stroke 1988; 19: 1501-1506.
7. World Health Organization. International statistical classification of diseases and related health problems, 10th revision, http://www.who.int/ dassifications/apps/icd/icd10online (accessed Dec 2006).
8. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143: 1257-1265.
9. Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series No. 31. http://www.who.int/healthinfo/paper31.pdf (accessed Nov 2006).
10. Daly LE, Bourke GJ. Multivariate analysis and the control of confounding. In: Interpretation and uses of medical statistics. 5th ed. Oxford: Blackwell Science, 2000: 339-380.
11. Daly LE, Bourke GJ. Confidence intervals: general principles; proportions, means, medians, counts and rates. In: Interpretation and uses of medical statistics. 5th ed. Oxford: Blackwell Science, 2000: 86-115.
12. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593.
13. Bergqvist D, Incidence of pulmonary embolism: is it declining? Semin Vasc Surg 2000; 13: 167-170.
14. Fraser JD, Anderson DR. Deep venous thrombosis: recent advances and optimal investigation with US. Radiology 1999; 211: 9-24.
15. Kearon C. Diagnosis of pulmonary embolism. CMAJ 2003; 168: 183-194.
16. Yusen RD, Gage BF. Outpatient treatment of acute venous thromboembolic disease. Clin Chest Med 2003; 24: 49-61.
17. Dager WE, King JH, Branch JM, et al. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis. Ann Pharmacother 2005; 39: 1182-1187.
18. Siragusa S, Arcara C, Malato A, et al. Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Ann Oncol 2005; 16 Suppl 4: iv136-iv139.
19. Nylander G, Olivecrona H. The phlebographic pattern of acute leg thrombosis within a defined urban population. Acta Chir Scand 1976; 142: 505-511.
20. Hankey GJ, Eikelboom JW, van Bockxmeer FM, et al. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke 2001; 32: 1793-1799.
21. van Bockxmeer FM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation factory V. Nat Med 1995; 1: 185.
22. Zöller B, Norlund L, Leksell H, et al. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis. Thromb Res 1996; 83: 475-477.